We understand that the development and launch of a practice-changing biotechnology requires years of financial and human capital. We can design and execute compelling analyses that will allow your payers to see the value that you see in your product. Examples of cost-related outcomes studies in which we have expertise include:
- Cost effectiveness analyses
- Strategic decision support
- Market size estimates
Examples of applications include:
- Cost effectiveness analysis that compares two genetic risk-stratifying assays in breast cancer to web-based clinical algorithms
- Use of value realization tools (VRT) to estimate the cost savings to an institution after adoption of a breast cancer recurrence assay or a novel analgesic agent
- Critical evaluation of the methods of a published cost-effectiveness analysis